Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.58)

# 2,103

Out of 5,154 analysts

2

Total ratings

100%

Success rate

33.82%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Patrick Dolezal

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NGNE Neurogene	Initiates: Outperform	$50	$22.13	+125.94%	1	Jan 26, 2026
	KOD Kodiak Sciences	Initiates: Outperform	$40	$25.16	+58.98%	1	Oct 23, 2025

Neurogene

Jan 26, 2026

Initiates: Outperform

Price Target: $50

Current: $22.13

Upside: +125.94%

Kodiak Sciences

Oct 23, 2025

Initiates: Outperform

Price Target: $40

Current: $25.16

Upside: +58.98%